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Schizophrenia is a disabling clinical syndrome found across 
the world. While the incidence and clinical expression of this 
illness are strongly influenced by ethnic factors, it is unclear 
whether patients from different ethnicities show distinct 
brain deficits. In this multicentre study, we used structural 
Magnetic Resonance Imaging to investigate neuroanatomy 
in 126 patients with first episode schizophrenia who came 
from 4 ethnically distinct cohorts (White Caucasians, 
African-Caribbeans, Japanese, and Chinese). Each patient 
was individually matched with a healthy control of the same 
ethnicity, gender, and age (±1 year). We report a reduction 
in the gray matter volume of the right anterior insula in 
patients relative to controls (P < .05 corrected); this reduc-
tion was detected in all 4 ethnic groups despite differences in 
psychopathology, exposure to antipsychotic medication and 
image acquisition sequence. This finding provides evidence 
for a neuroanatomical signature of schizophrenia expressed 
above and beyond ethnic variations in incidence and clini-
cal expression. In light of the existing literature, implicat-
ing the right anterior insula in bipolar disorder, depression, 
addiction, obsessive-compulsive disorder, and anxiety, we 
speculate that the neuroanatomical deficit reported here 
may represent a transdiagnostic feature of Axis I disorders.
Key words: schizophrenia/neuroanatomy/ethnicity/ 
magnetic resonance imaging/voxel-based morphometry
Schizophrenia is common, severely disabling, and has major 
socioeconomic impact. Consistent with the current under-
standing of illness as a collection of heterogeneous clini-
cal syndromes,1,2 epidemiological studies have found that 
the incidence and clinical expression of schizophrenia vary 
according to a number of sociodemographic factors includ-
ing, amongst others, the ethnic origin of the patients under 
investigation.3–7 For example, patients from Asian ethnicities 
are more likely to experience visual hallucinations, whereas 
patients from western cultures and Caucasian ethnicities 
are more likely to suffer from auditory hallucinations.5 In 
addition, the content of hallucination and delusions is also 
strongly influenced by the patient’s ethnic milieus.5 Even 
within the same geographical area, ethnic origin has been 
found to strongly influence the incidence and manifestation 
of the disease. For example, African-Caribbeans living in 
London are more likely to develop schizophrenia6 and suf-
fer from affective symptoms7 than White Caucasians from 
the same neighbourhood. Likewise, Mâori people in New 
Zealand are more likely to present with hallucinations and 
aggression and less likely to present with depression and 
self-harm than non-Mâori people from the same area.8
Over the past 2 decades, neuroimaging techniques have 
enabled greater understanding of the neuroanatomi-
cal basis of this illness.9–14 So far, however, the impact of 
ethnic characteristics on the neuroanatomical basis of 
schizophrenia has received minimal attention in the exist-
ing literature.15 Some neuroimaging studies have recruited 
ethnically uniform cohorts in order to minimize individual 
variation within each experimental group16,17; whereas other 
studies have included participants from a range of ethnic 
backgrounds based on the assumption that this would not 
have a significant impact on the results.10,18 Thus, at pres-
ent, we know very little about whether patients from dif-
ferent ethnicities are characterised by similar or different 
neuroanatomical deficits. Here, we addressed this question 
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by investigating 4 ethnically distinct samples comprising of 
(1) White Caucasian, (2) African-Caribbean, (3) Japanese, 
and (4) Chinese participants. The 4 groups were uniform 
with respect to the stage of the illness, as all patients had 
experienced a first episode of schizophrenia within the pre-
vious 24 months. In addition, in all 4 groups, each patient 
was individually matched with a healthy control of the 
same ethnicity, gender, and age (±1 year) in order to mini-
mize the potential impact of these demographic variables. 
As the 4 groups were scanned at different sites using dif-
ferent scanners and acquisition sequences (see supplemen-
tary table S1 for detail), any discrepancy between datasets 
could be due to methodological differences. For the pur-
pose of the present investigation, therefore, we focussed 
on differences between patients and controls that were 
expressed consistently across the 4 groups. As we prepro-
cessed and analysed each dataset independently, using eth-
nic-specific templates, our investigation can be thought of 
as a series of replication studies across 4 independent data-
sets. We hypothesised that the 4 groups would show con-
sistent neuroanatomical reductions in specific prefrontal, 
parietal, and limbic regions that are implicated in existing 
animal19 and human11,20–24 models of schizophrenia. This 
would provide evidence for a neuroanatomical signature 
of schizophrenia expressed above and beyond ethnic dif-
ferences in incidence and clinical expression.
Methods
Participants
We recruited a total of 126 patients (age range: 18–44; 
all right-handed) who had experienced a first episode of 
schizophrenia within the previous 24  months and 126 
healthy controls (age range: 18–44; all right-handed). The 
patient group comprised 4 distinct samples differing in 
terms of self-ascribed ethnicity; these included 29 White 
Caucasians, 19 African-Caribbean, 28 Japanese, and 50 
Chinese. The White Caucasian and African-Caribbean 
samples were recruited from the South London and 
Maudsley Foundation Trust and scanned at the Institute 
of Psychiatry (United Kingdom) between 2008 and 2012. 
The Japanese sample was recruited from and scanned at 
University of Tokyo Hospital (Japan) between 2010 and 
2013; a subset of this sample was included in a previous 
publication.25 The Chinese sample was recruited from the 
West China Hospital of Sichuan University and scanned 
at the Huaxi MR Research Center in Chengdu (China) 
between 2009 and 2012. Diagnosis of schizophrenia was 
formulated by an experienced psychiatrist using the ICD-
10 criteria (for the White Caucasians, African-Caribbean, 
and Chinese samples) or the DSM-V criteria (for the 
Japanese sample). In addition, psychotic symptoms were 
evaluated using the Positive and Negative Syndrome 
Scale (PANSS)26 on the day of scanning (for the White 
Caucasians, African-Caribbean, and Chinese samples) or 
within 7 days (for the Japanese sample). All patients in 
the Chinese sample were medication naïve at the time of 
scanning; in contrast, patients in the White Caucasian, 
African-Caribbean and Japanese samples were taking 
first- or second-generation antipsychotic medication, or 
a combination of the two (see table 1 for chlorpromazine-
equivalent dose). Each patient group was recruited as part 
of a larger single-center project, and comprised a mixture 
of in- and outpatients. The healthy controls were recruited 
through local advertisement from the same geographi-
cal areas as patients, and were individually matched to 
patients on age (±1 year), gender, and ethnicity. A screen-
ing tool (the Psychosis Screening Questionnaire27 for the 
White Caucasians, African-Caribbean, and Chinese sam-
ples; the Mini-International Neuropsychiatric Interview28 
for the Japanese sample) was used to exclude the presence 
of psychotic symptomatology or a history of psychotic 
illness. Additional exclusion criteria for all participants 
included learning disabilities (based as an IQ < 70), cur-
rent or past neurological illness, brain injury with loss 
of consciousness for more than 1 hour and suspected or 
confirmed pregnancy. Ethical approval was granted from 
the relevant Ethics Committees, and written informed 
consent was obtained from all participants.
Image Acquisition
At all sites, volumetric MR images were acquired using 
a T1- weighted protocol. All sites used General Electric 
scanners with a field strength of 3T. The details of the 
image acquisition sequence varied between scanners, as 
reported in supplementary table S1.
Statistical Analysis of Sociodemographic and Clinical 
Parameters
Differences in demographics and clinical profile between 
groups were examined using 1-way ANOVA for paramet-
ric data and a chi-square test for nonparametric data, 
as implemented in the Statistical Package for the Social 
Sciences 17.0 (SPSS 17.0 for Windows).
Statistical Analysis of MRI Data
To minimize the impact of ethnicity and acquisition 
sequence on the results, we preprocessed and analysed 
each dataset independently; thus, our investigation can 
be thought of as a series of replication studies carried out 
on 4 independent datasets. Our aim was to identify differ-
ences in gray matter volume (GMV) between patients and 
controls that would be expressed consistently across all 4 
datasets; in contrast, we did not test for differences across 
datasets as these would not be easily interpretable due to 
inconsistencies in sample size and acquisition sequence. 
The T1-weighted volumetric images were preprocessed 
using voxel-based morphometry as implemented in 
SPM8 software (http://www.fil.ion.ucl.ac.uk/spm) run-
ning under Matlab 7.1 (Math Works). In particular we 
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used the Diffeomorphic Anatomical Registration using 
Exponentiated Lie algebra (DARTEL) SPM8 toolbox29; 
this involves the creation of a dataset-specific template 
and the segmentation of each individual image using 
such template, with the aim of maximizing accuracy and 
sensitivity.30 The following steps were followed: (1) check-
ing for scanner artifacts and gross anatomical abnormali-
ties for each subject; (2) setting the image origin to the 
anterior commissure; (3) using the DARTEL toolbox 
to produce a high-dimensional normalization protocol; 
(4) checking for homogeneity across the sample; and (5) 
using standard smoothing (ie, 8 mm). A  “modulation 
step” was also included in the normalization in order to 
preserve the information about the absolute gray matter 
values.31 After the preprocessing, we obtained smoothed, 
modulated, normalized images for each of our 4 data-
sets. These were used to compare patients and controls 
using a 2-sample t test, with age, gender and total GMV 
modeled as covariates of no interest, for each dataset 
independently.
This analysis focused on 22 regions of interest that are 
implicated in contemporary animal19 and human11,20–24 
models of schizophrenia; see table 2 for complete list. The 
identification of these regions was carried out using the 
Automated Anatomical Labeling atlas as implemented 
in PickAtlas software (http://fmri.wfubmc.edu/software/
PickAtlas). Statistical inferences were made at P < .05 
with Bonferroni correction for multiple comparisons 
resulting in a corrected P value < .0022. For each region 
and each dataset, we also report Cohen’s d to provide an 
indication of the effect size.32
Following the identification of regional differences 
between patients and controls across all 4 datasets, we 
performed a series of follow-up analyses to explore the 
relationship between GMV in these regions and 8 vari-
ables of interest including age, gender, years of education, 
PANSS score total, PANSS score positive, PANSS score 
negative, PANSS score general, and exposure to antipsy-
chotic medication (ie, chlorpromazine-equivalent dose). 
For each dataset, this involved extracting the GMV from 
the peak voxels in each ethnic sample and performing a 
total of 8 correlation analyses with age, gender and total 
GMV as covariates of no interest, using SPSS (Statistical 
Package for Social Sciences – version 23). In these explor-
atory analyses, statistical inferences were made at P < .05 
(uncorrected).
Results
Sociodemographic and Clinical Parameters
The sociodemographic and clinical characteristics of our 
samples are reported in Table 1.
With respect to sociodemographic parameters, within 
each group patients and controls were individually matched 
for ethnicity, gender and age (±1 year); hence these vari-
ables did not differ between patients and controls in any of 
the 4 groups (P > .05). Years of education differed between 
patients and controls in the Japanese group (t = 4.02, P < 
.001) but not in the African-Caribbean (t = 0.63, P = .53), 
White Caucasian (t = 1.03, P = .331), and Chinese (t = 1.8, 
P = .08) groups. Between groups, there were no significant 
differences in age (F[3,122]  =  1.58, P  =  .19). However, 
there was a difference in education (F[3,122]  =  6.39, P 
< .001) and gender (Pearson χ2 = 15.6, df = 3, P = .001). 
Newman-Keuls post hoc tests on education revealed that 
the Chinese group had fewer years of education than the 
Japanese (P =  .019), African-Caribbean (P =  .034), and 
White Caucasian (P = .057) groups. Chi-square tests on 
pairwise comparisons on gender indicated differences 
between the Japanese and African-Caribbean groups (P 
< .0001), between the African-Caribbean and Chinese 
groups (P  =  .007), and between the African-Caribben 
and White Caucasian (P = .01) groups. In addition, there 
were differences at trend level between the Japanese and 
Chinese groups (P = .054) and between the Japanese and 
White Caucasian groups (P = .079). In contrast, there were 
no differences between the Chinese and White Caucasian 
groups (P = .97)
With respect to clinical parameters, there was a differ-
ence in PANSS total (F[3,122] = 4165, P < .001), PANSS 
positive (F[3,122]  =  35.08, P < .001), and PANSS gen-
eral (F[3,112]  =  36.82, P < .001) scores across groups 
(table 1). Post hoc t tests indicated that these differences 
were driven by the Chinese group having higher scores in 
PANSS total, PANSS positive, and PANSS general than 
the Japanese, African-Caribbean, and White Caucasian 
groups (P < .001); in contrast, the 4 groups did not dif-
fer in terms of PANSS negative scores (F[3,112]  =  1, 
P  =  .39). In addition, there was a difference in dura-
tion of illness (F[3,122] = 6.76, P = .0003) across groups 
(table 1). Post hoc t tests indicated that these differences 
were driven by the Japanese group having longer duration 
of illness than the African-Caribbean (P = .01) and the 
White Caucasian (P = .007) groups, and by the Chinese 
group having longer duration of illness than the African-
Caribbean (P = .005) and the White Caucasian (P = .004) 
groups. In contrast, there were no statistically significant 
differences in duration of illness between the Japanese 
and Chinese groups (P = .63) and between the African-
Caribbean and White Caucasian groups (P = .83).
The 4 groups differed with respect to daily exposure 
to Chlorpromazine-equivalent dose of antipsychotic 
medication (F[3,122] = 34.7, P < .001; table 1). Newman-
Keuls post hoc test revealed that the Chinese patients, 
who were all medication-naïve, differed from the other 
groups who were receiving medication (for all compari-
sons, P < .001). In addition, the Japanese group was 
receiving a higher dose than the African-Caribbean (P < 
.01) and the White Caucasian (P < .01) group; in con-
trast, the African-Caribbean and the White Caucasian 
groups did not differ between them (P =  .36). In addi-
tion, the 4 groups differed with respect to duration of 
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antipsychotic exposure (F[3,122]  =  6.74, P  =  .0003). 
Newman-Keuls post hoc test revealed that the Chinese 
patients, who were all medication-naïve, differed from 
the other groups who had received medication; in con-
trast, there were no statistically significant differences in 
duration of antipsychotic exposure between the Japanese 
and the African-Caribbean (P = .82) groups; between the 
White Caucasian and the African-Caribbean (P  =  .11) 
groups; and between the White Caucasian and the 
Japanese (P = .1) groups.
Gray Matter Volume
The right anterior insula showed decreased GMV in 
patients relative to controls (P < .05 corrected) consis-
tently in all 4 groups (figure 1; table 2). Follow-up anal-
yses indicated that gray matter in this region was not 
associated with age, gender, or years of education in any 
of the 4 samples (P < .05). Furthermore, gray matter in 
this region was not associated with any of the PANSS 
scores or exposure to antipsychotic medication (ie, chlor-
promazine-equivalent dose) in any of the patient groups 
(P > .05).
In addition, 3 regions (the left and right inferior fron-
tal gyrus and the right supramerginal gyrus) showed 
decreased GMV in patients relative to controls (P < .05 
corrected) in 3 out of the 4 groups (table 2); 6 regions (the 
left anterior insula, right middle temporal gyrus, left and 
right superior temporal gyrus, and left and right parahip-
pocampus) showed decreased GMV in patients relative 
to controls (P<0.05 corrected) in 2 out of the 4 groups 
(table 2); and 6 regions (left caudatus, left supramarginal 
gyrus, left middle temporal gyrus, right anterior hippo-
campus, right posterior hippocampus, and right anterior 
cingulate cortex) showed decreased GMV in patients rel-
ative to controls (P < .05 corrected) in just 1 out of the 
4 groups (table 2). Again, none of these regions showed 
an association with medication (ie, chlorpromazine-
equivalent dose) in any of the 3 groups who had received 
pharmacological treatment (White Caucasian, African-
Caribbean, and Japanese; P > .05).
The P value and effect size for the comparison “con-
trols > patients” in each of our region of interest and 
each dataset are reported in table  2; in addition, mean 
and SE of  GMV in these regions are reported for patients 
and controls separately in supplementary table S2.
Discussion
The clinical expression and even the incidence of schizo-
phrenia vary depending on the ethnic origin of the patients 
under investigation; at present, it is unclear whether 
schizophrenia is characterized by a neuroanatomical sig-
nature that is expressed above and beyond these ethnic 
differences. Here we tested for consistent neuroanatomi-
cal alternations in 4 ethnically diverse groups of patients 
with first episode schizophrenia; as we preprocessed and 
analysed each dataset independently, using ethnic-spe-
cific templates, our investigation can be thought of as a 
series of replication studies carried out on 4 independent 
datasets. A  strength of the present investigation is that 
we individually matched patients and controls for gen-
der and age (±1 year); given the impact of these variables 
on GMV,33 this is likely to have increased the sensitivity 
Fig. 1. Region of the right anterior insula that showed reduced gray matter volume in patients relative to healthy controls consistently 
in each of the 4 datasets. The asterisk (*) indicates a statistically significant difference at P < .05 with Bonferroni correction for multiple 
comparisons. GMV = gray matter volume measured as mm3 of gray matter per voxel. 1 = Japanese; 2 = African-Caribbean; 3 = White 
Caucasian; 4 = Chinese.
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of our statistical analysis. A  further strength is that all 
participants were at the early stage of the illness, in con-
trast with the majority of previous studies that included 
patients at different stages of illness; again, this may have 
increased the sensitivity of our statistical analysis by 
minimizing the neuroanatomical variability associated 
with illness progression.34 We found a consistent reduc-
tion in the GMV of the right anterior insula; remarkably, 
this reduction was detected across all 4 ethnic groups 
despite differences in symptomatology, exposure to anti-
psychotic medication and image acquisition sequence. 
Furthermore, gray matter in this region was not associ-
ated with chlorpromazine-equivalent dose in any of the 
3 groups who had received pharmacological treatment. 
This is consistent with the notion of a neuroanatomical 
signature of early schizophrenia above and beyond ethnic 
differences in the manifestation of the disease.
The right anterior insula has ipsilateral reciprocal con-
nections with several prefrontal and temporal cortical 
regions,35 as well as with subcortical structures including 
the thalamus and the amygdala.36 It is considered part 
of the limbic system, and as such has been implicated in 
self-awareness,37 emotional regulation,38 and the process-
ing of salience,39 3 aspects of mental functioning that are 
known to be affected in schizophrenia.40 There is a wealth 
of neuroimaging evidence suggesting that the right ante-
rior insula is structurally and functionally impaired both 
in prodromal and established schizophrenia.23,24,41–48 For 
example, GMV in the right anterior insula is inversely 
related to both negative and positive symptomatology in 
people with an at-risk mental state, and is associated with 
individual risk of transition to psychosis42; in addition, 
a reduction of GMV in this region can be observed in 
patients with first episode and chronic schizophrenia rela-
tive to healthy controls,20–24,49 and is associated with sever-
ity of positive symptoms.50 The vast majority of above 
studies, however, were typically carried out in people of 
White Caucasian origin. The present investigation extends 
the existing literature by showing that gray matter reduc-
tion in the right anterior insula can be detected in the 
early stages of the illness irrespective of the ethnic char-
acteristics of the patients. It should be noted, however, 
that the exact location of this reduction varied slightly 
from one dataset to the other (figure 1 and table 2). This 
is not surprising given that the 4 datasets were acquired 
using different scanners and acquisition parameters and 
were processed separately using ethnic-specific templates.
At present, we have no reliable biomarkers to identify 
individuals with schizophrenia, and the diagnosis of this 
disorder is still entirely reliant on clinical presentation 
and psychometric measures.51 The finding of consistent 
gray matter reduction in the right anterior insula, evident 
after a single episode of the illness irrespective of expo-
sure to antipsychotic medication, suggests that this region 
might provide valuable information that could be used 
to inform diagnostic evaluations. Future studies could 
examine the clinical applicability of this finding in terms 
of accuracy, sensitivity, and specificity, using supervised 
machine learning techniques that allow inferences at indi-
vidual rather than group level.52 Ideally, any evaluation 
of clinical applicability should go beyond the comparison 
between patients and controls, and consider the useful-
ness of the right anterior insular deficit reported here for 
distinguishing between alternative diagnostic options. For 
example, a recent meta-analytic investigation, including 
193 published studies and a total of 15 892 participants, 
found that gray matter loss in the right anterior insula is 
not specific to schizophrenia but can also be seen in bipo-
lar disorder, depression, addiction, obsessive-compulsive 
disorder and anxiety.53 In light of the existing literature, 
therefore, we speculate that the right anterior insular defi-
cit reported here may represent a transdiagnostic feature 
of most if  not all Axis I disorders. Consistent with this 
interpretation, we note that schizophrenia’s diagnostic 
boundaries are not clear cut, and that its etiology, psy-
chopathology and treatment tend to overlap with those 
of other Axis I  disorders.54 In particular, right anterior 
insular alteration could reflect cognitive impairment and/
or emotional dysfunction—2 deficits have been associ-
ated with anterior insular alteration and that tend to co-
occur across developmental and adult disorders53,55,56
The observation of a neuroanatomical signature of 
schizophrenia in the right anterior insula across different 
ethnic groups, does not exclude the presence of further 
neuroanatomical alterations associated with the ethnic 
origin of the patients. For example, different sets of genes 
might confer vulnerability to schizophrenia in different 
ethnic groups, resulting in ethnicity-specific neuroana-
tomical alterations.57 Furthermore, the different patterns 
of symptoms expressed in different ethnic groups might 
be associated with different patters of neuroanatomi-
cal alteration. Indeed the observation of several regions 
showing gray matter differences in some but not all 
the 4 groups would appear to support this notion. We 
speculate that at least some of the group-specific effects 
reported in table 2 reflect real differences across ethnici-
ties rather than the use of different scanners and acquisi-
tion sequences. In order to address this issue, one would 
need to scan all participants at a single centre or use a 
harmonised acquisition sequence.58 A  further limitation 
of the present study is that there were a number of meth-
odological differences across the 4 datasets; for example, 
the diagnosis of schizophrenia was made using the ICD-
10 criteria in 3 groups and the DSM-V criteria in 1 group 
(see Material and Methods); exposure to antipsychotic 
medication differed between some of the groups (table 1); 
and, although all datasets were acquired using a 3T scan-
ner, the specific acquisition sequence differed between 
some of the sites (supplementary table S1). Given the 
focus of the present study on effects that were expressed 
consistently across datasets, these methodological differ-
ences are most unlikely to account for our main finding in 
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the right anterior insula. However, it is possible that these 
methodological differences prevented us from detecting 
further regions expressed consistent alterations across 
ethnicities. A third limitation relates to the definition of 
ethnicity. While race is defined based on a combination 
of genetic and cultural factors, ethnicity is considered an 
entirely social-political construct, referring to the shar-
ing of a common culture, including origin, psychologi-
cal attitudes, language, religion, and traditions.59 For this 
reason, we used self-ascribed ethnicity as a valid and reli-
able indicator of ethnicity, consistent with the existing lit-
erature.15,60,61 However, we acknowledge that self-declared 
ethnicity may not be fully accurate for a multitude of 
possible reasons including, for example, nonpaternity 
and failing to recognize or appreciate mixed heritage in 
previous generations.61 A final limitation is that, although 
patients and controls were matched for ethnicity, age and 
gender, other potential confounding variables were not 
controlled for. For example, parental socioeconomic sta-
tus contributes to health disparities in most countries and 
accounts for some of the executive deficits observed in 
patients with schizophrenia relative to healthy controls62; 
however, we note that a recent investigation of the impact 
of this variable on brain structure did not detect a signifi-
cant effect in the right anterior insula.62
In conclusion, our investigation provides evidence for 
a right anterior insular deficit in first episode schizo-
phrenia, expressed above and beyond ethnic variations 
in incidence and clinical expression. In light of the exist-
ing literature, implicating this region in bipolar disorder, 
depression, addiction, obsessive-compulsive disorder, 
and anxiety, we speculate that this deficit may represent a 
transdiagnostic feature of Axis I disorders.
Supplementary Material
Supplementary material is available at http://schizophre-
niabulletin.oxfordjournals.org.
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